PromoExQ Portfolio
Excipient GMP-grade media for human cell culture to streamline your path from research to clinical application.
Receive your quote directly from the manufacturer.
Our PromoExQ portfolio of Excipient GMP-grade cell culture media was developed to support the transition from research to clinical applications in cell therapy and regenerative medicine.
Designed for the expansion and maintenance of various human cell types, PromoExQ media are available off-the-shelf, ensuring immediate access and consistent performance. Whether working with primary stem cells or somatic cells, users benefit from high-quality raw materials sourced from qualified suppliers and supported by comprehensive documentation. This ensures traceability, transparency, and confidence at every stage of your workflow.
A key advantage of the PromoExQ portfolio is its seamless compatibility with PromoCell’s research-grade media, allowing users to begin development with research-grade formulations and transition effortlessly to Excipient GMP-grade versions within the same product family. This continuity simplifies qualification processes and accelerates development timelines, making it easier to scale from discovery to clinical manufacturing.
PromoExQ is aligned with the needs of clinical and commercial environments, offering not just media, but a streamlined path through regulatory landscapes. With expert technical support and a commitment to quality, PromoExQ helps you move forward with confidence.
